They Walk Among Us - UK True Crime

They Walk Among Us is an award-winning weekly UK true crime podcast covering a broad range of cases from the sinister to the surreal. Support this show http://supporter.acast.com/theywalkamongus. Hosted on Acast. See acast.com/privacy for more information.

http://theywalkamonguspodcast.com

subscribe
share






episode 37: Bonus Episode 37


At the beginning of the 20th century, new medications were being discovered and created. The term ‘miracle drug’ was coined to describe the sudden positive effect of newly discovered remedies for once untreatable diseases and conditions. But, one person's cure can be another person's poison… 


*** LISTENER CAUTION IS ADVISED *** 

  

This episode was researched and written by Eileen Macfarlane.


Edited by Joel Porter at Dot Dot Dot Productions.


Script editing, additional writing, illustrations and production direction by Rosanna Fitton


Narration, audio editing assistance, additional writing, and production direction by Benjamin Fitton.


Become a ‘Patreon Producer’ and get exclusive access to Season 1, early ad-free access to episodes, and your name in the podcast credits. Find out more here: https://www.patreon.com/TheyWalkAmongUs


More information and episode references can be found on our website https://theywalkamonguspodcast.com


MUSIC: 


Azure by Alice in Winter 

End of an Era by Salon Dijon 

Unexpected Turn by Moments 

Those Lost by Moments 

Stratos by Lone Canyon 

Strangers by Craig Allen Fravel 

Wolgrim by Cody Martin 

Shadow Passage by Cody Martin 

Intercept by Cody Martin 

Forbidden Wing by Cody Martin 


SOCIAL MEDIA: 


X - https://twitter.com/TWAU_Podcast

Facebook - https://www.facebook.com/theywalkamonguspodcast

Instagram - https://www.instagram.com/theywalkamonguspodcast

Threads - https://www.threads.net/@theywalkamonguspodcast

Support this show http://supporter.acast.com/theywalkamongus.


Hosted on Acast. See acast.com/privacy for more information.


fyyd: Podcast Search Engine
share








 March 6, 2024  29m